Thomas J. Schall
2011
In 2011, Thomas J. Schall earned a total compensation of $652.7K as President and Chief Executive Officer at ChemoCentryx, a 62% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $186,300 |
|---|---|
| Salary | $465,750 |
| Other | $690 |
| Total | $652,740 |
Schall received $465.8K in salary, accounting for 71% of the total pay in 2011.
Schall also received $186.3K in non-equity incentive plan and $690 in other compensation.
Rankings
In 2011, Thomas J. Schall's compensation ranked 7,210th out of 10,747 executives tracked by ExecPay. In other words, Schall earned more than 32.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,210 out of 10,747 | 33rd |
Division Manufacturing | 2,630 out of 3,960 | 34th |
Major group Chemicals And Allied Products | 634 out of 1,033 | 39th |
Industry group Drugs | 437 out of 781 | 44th |
Industry Pharmaceutical Preparations | 340 out of 571 | 41st |
Source: SEC filing on March 29, 2013.
Schall's colleagues
We found three more compensation records of executives who worked with Thomas J. Schall at ChemoCentryx in 2011.